Zacks Investment Research
11 Nov 2025, 00:57 UTC · 51w ago
Verdict
Headline leans bearish. We score OM −0.80 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.80strongly bearish
More negative than 92% of ticker scores this week
Top 1 mover · tap to explore
What the story claims
3 claims · scored −1 bearish … +1 bullish
Outset Medical reported a quarterly loss of $0.69 per share, missing the Zacks Consensus Estimate of a $0.64 loss.
More negative than 85% of claims this week
Outset Medical's quarterly revenues of $29.43 million missed the Zacks Consensus Estimate by 3.19%.
So whatA revenue miss indicates slower-than-expected growth, which negatively impacts valuation.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 78% of claims this week
Outset Medical shares have decreased approximately 27.5% year-to-date, significantly underperforming the S&P 500's 14.4% gain.
More negative than 65% of claims this week
Which stocks this story touches
More negative than 92% of ticker scores this week
The company reported an earnings miss, a revenue miss, and shares have declined 27.5% year-to-date.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
3h ago
−66.0%
Price agrees with the score
$4.10 vs $12.07 close before publication (Nov 10) · not market-adjusted
OM chart →
